Elevated Akt Activation and Its Impact on Clinicopathological Features of Renal Cell Carcinoma
- 1 February 2003
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 169 (2) , 710-713
- https://doi.org/10.1016/s0022-5347(05)63998-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The AKT kinase is activated in multiple myeloma tumor cellsBlood, 2001
- Frequent Loss of PTEN Expression Is Linked to Elevated Phosphorylated Akt Levels, but Not Associated with p27 and Cyclin D1 Expression, in Primary Epithelial Ovarian CarcinomasThe American Journal of Pathology, 2001
- Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancerOncogene, 2000
- Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by AktScience, 1999
- Forkhead transcription factors: new insights into protein kinase B (c-akt) signalingJournal of Molecular Medicine, 1999
- Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription FactorCell, 1999
- Regulation of Cell Death Protease Caspase-9 by PhosphorylationScience, 1998
- PI3K: Downstream AKTion Blocks ApoptosisCell, 1997
- Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transductionNature, 1995
- The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinaseCell, 1995